Morning Movers 8/12: HLCS, EJ, JAZZ, CYTR, WX, CAAS Higher; GU, JASO, VISN, LIZ, BOBE, YRCW Lower Aug 12, 2009 09:25AM

Helicos BioSciences Corporation (NASDAQ: HLCS) 24.8% HIGHER; continuing higher from news on Monday of the publication of a breakthrough study in which a Helicos(TM) Genetic Analysis System was used to sequence a human genome at the Stanford Institute for Stem Cell and Regenerative Medicine. Here is the full report.

E-House (China) Holdings Limited (NYSE: EJ) 18.5% HIGHER; reports Q2 non-GAAP EPS of $0.27, 10 cents better than the analyst estimate of $0.17. Revenue for the quarter was $63.5 million, versus the consensus of $50.67 million. Sees Q3 revs of $78-$80 million, versus the consensus of $52.66 million.

Jazz Pharmaceuticals (Nasdaq: JAZZ) 18.4% HIGHER; reports Q2 EPS of $0.07, compared to a loss of $2.17 in the same quarter last year. Revenue for the quarter was $37.3 million, versus $15.5 million in Q208. Sees FY09 sales of $112-$122 million.

CytRx Corporation (NASDAQ: CYTR) 16% HIGHER; today announced that ...